Vasculitis in the News (RSS News Feeds)
- Vasculitis Treatment Market Transform Health Care Sector to New Peak – The Industry Chronicle (press release) (blog)
- Vasculitis Treatment Market by Types , Applications and by Region – Global Trends and Forecast to 2021 – RBTE Report
- FDA expands approval of Rituxan for two rare forms of vasculitis – Healio
- Development of New Drugs Fuels the Vasculitis Treatment Market – Coherent News (press release) (blog)
- Development of New Drugs Fuels the Vasculitis Treatment Market – Coherent News (press release) (blog)
- Vasculitis Treatment Market is expected to register the Highest CAGR according to market forecasts – Tampa Bay Review
- FDA approves update to Rituxan label to include information on treatment of rare forms of vasculitis – News-Medical.net
- PET/CT combination accurately diagnoses giant cell arteritis – Healio
- Global Vasculitis Drug Market- By Key Players, Type, Application, Region, and Forecast 2018-2025 – realcriticism.com
- ACR and EULAR Present Drafts of New Classification Criteria for Large-Vessel Vasculitis – Newswise (press release)
- FDA OKs Rituximab Label Update for 2 Rare Forms of Vasculitis – Specialty Pharmacy Times
- FDA OKs Rituximab Label Update for 2 Rare Forms of Vasculitis – Specialty Pharmacy Times
- FDA Approves Label Update for Genentech’s Rituxan (Rituximab) in Two Rare Forms of Vasculitis – BioSpace (press release) (blog)
- FDA Approves Label Update for Genentech’s Rituxan (Rituximab) in Two Rare Forms of Vasculitis – Associated Press (press release)
- FDA Approves Label Update for Genentech’s Rituxan (Rituximab) in Two Rare Forms of Vasculitis – Business Wire (press release)